These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18227759)

  • 21. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
    Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC
    Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion.
    Lynch JP
    Semin Respir Crit Care Med; 2009 Oct; 30(5):596-610. PubMed ID: 19760547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix-assisted laser desorption ionisation-time-of of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex.
    Vanlaere E; Sergeant K; Dawyndt P; Kallow W; Erhard M; Sutton H; Dare D; Devreese B; Samyn B; Vandamme P
    J Microbiol Methods; 2008 Oct; 75(2):279-86. PubMed ID: 18627778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of Burkholderia cepacia complex in septicaemic patients in a tertiary care hospital, India.
    Gautam V; Ray P; Puri GD; Sharma K; Vandamme P; Madhup SK; Das A; Malhotra P; Trehan A; Garg RK; Rana S; Koushal V; Kumar A
    Nepal Med Coll J; 2009 Dec; 11(4):222-4. PubMed ID: 20635597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
    Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA
    APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.
    Peeters E; Nelis HJ; Coenye T
    J Antimicrob Chemother; 2009 Oct; 64(4):801-9. PubMed ID: 19633000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous coinfection by multiple strains during Burkholderia cepacia complex infection in cystic fibrosis.
    Yang JH; Spilker T; LiPuma JJ
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):95-8. PubMed ID: 16406186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An outbreak of Burkholderia cepacia bacteremia in hospitalized hematology patients selectively affecting those with acute myeloid leukemia.
    Vardi A; Sirigou A; Lalayanni C; Kachrimanidou M; Kaloyannidis P; Saloum R; Anagnostopoulos A; Sotiropoulos D
    Am J Infect Control; 2013 Apr; 41(4):312-6. PubMed ID: 23040605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complex.
    Tabacchioni S; Ferri L; Manno G; Mentasti M; Cocchi P; Campana S; Ravenni N; Taccetti G; Dalmastri C; Chiarini L; Bevivino A; Fani R
    FEMS Microbiol Lett; 2008 Apr; 281(2):175-82. PubMed ID: 18312571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Green and red fluorescent protein vectors for use in biofilm studies of the intrinsically resistant Burkholderia cepacia complex.
    Tomlin KL; Clark SR; Ceri H
    J Microbiol Methods; 2004 Apr; 57(1):95-106. PubMed ID: 15003692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
    Herasimenka Y; Cescutti P; Impallomeni G; Campana S; Taccetti G; Ravenni N; Zanetti F; Rizzo R
    J Cyst Fibros; 2007 Apr; 6(2):145-52. PubMed ID: 16860003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibility of Burkholderia cepacia complex isolates: Comparison of disk diffusion, Etest®, agar dilution, and broth microdilution methods.
    Fehlberg LC; Nicoletti AG; Ramos AC; Rodrigues-Costa F; de Matos AP; Girardello R; Marques EA; Gales AC
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):422-427. PubMed ID: 27638346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
    Lekkas A; Gyi KM; Hodson ME
    J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of species-specific recA PCR tests in the identification of Burkholderia cepacia complex environmental isolates.
    Dalmastri C; Pirone L; Tabacchioni S; Bevivino A; Chiarini L
    FEMS Microbiol Lett; 2005 May; 246(1):39-45. PubMed ID: 15869960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of essential oils against multidrug-resistant clinical isolates of the Burkholderia cepacia complex.
    Vasireddy L; Bingle LEH; Davies MS
    PLoS One; 2018; 13(8):e0201835. PubMed ID: 30071118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the Interplay of Resistance Nodulation Division Efflux Pumps,
    Gautam V; Kumar S; Patil PP; Meletiadis J; Patil PB; Mouton JW; Sharma M; Daswal A; Singhal L; Ray P; Singh M
    Microb Drug Resist; 2020 Oct; 26(10):1144-1152. PubMed ID: 32354297
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of reduced pH on inorganic polyphosphate accumulation by Burkholderia cepacia complex isolates.
    Moriarty TF; Mullan A; McGrath JW; Quinn JP; Elborn JS; Tunney MM
    Lett Appl Microbiol; 2006 Jun; 42(6):617-23. PubMed ID: 16706902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel.
    Nannini EC; Ponessa A; Muratori R; Marchiaro P; Ballerini V; Flynn L; Limansky AS
    Braz J Infect Dis; 2015; 19(5):543-5. PubMed ID: 26322722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center.
    Cunha MV; Pinto-de-Oliveira A; Meirinhos-Soares L; Salgado MJ; Melo-Cristino J; Correia S; Barreto C; Sá-Correia I
    J Clin Microbiol; 2007 May; 45(5):1628-33. PubMed ID: 17360834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia.
    Rajyaguru JM; Muszynski MJ
    J Antimicrob Chemother; 1997 Dec; 40(6):803-9. PubMed ID: 9462431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.